Mesothelioma cancer  |   Types of mesothelioma  |   Traditional mesothelioma treatment  |  
Non-traditional mesothelioma treatment  |   Mesothelioma support  |   Law mesothelioma  |  
Mesothelioma articles  |   Mesothelioma additional information  |   Mesothelioma and asbestos

Home > Mesothelioma cancer > Mesothelioma cancer terms list

Mesothelioma cancer terms list

A
ABCD rating
ablation
abscess
action study
acute
acute lymphoblastic leukemia
acute lymphocytic leukemia
acute myelogenous leukemia
acute myeloid leukemia
acute nonlymphocytic leukemia
adenocarcinoma
adjunct agent
adjunctive therapy
adjuvant therapy
adverse effect
agent study
aggressive
agranulocyte
AJCC staging system
alkaloid
alkylating agent
ALL
allogeneic
allogeneic bone marrow transplantation
allogeneic stem cell transplantation
allogenic
all-trans retinoic acid
alpha-fetoprotein
AML
analgesic
analog
anaphylactic shock
anaplastic
androgen
androgen ablation
androgen suppression
androgen-independent
anemia
anesthesia
anesthesiologist
anesthetic
angiogenesis
angiogenesis inhibitor
angiostatin
antiangiogenesis
antibiotic
antibody
antibody therapy
antiestrogen
antifolate
antifungal
antigen
antigen-presenting cell
antigen-presenting cell vaccine
antihormone therapy
antimetabolite
antimicrotubule agent
antimitotic agent
antineoplaston
antiparasitic
apheresis
apnea
apoptosis
arctigenin
arctiin
arginine butyrate
aromatase inhibitor
arsenic
arsenic trioxide
arterial embolization
arthralgia
asbestos
asbestos bodies
asbestosis
ascites
asthenia
astrocytoma
ataxia
ataxic gait
athymic, nude mouse
atypical teratoid/rhabdoid tumor
autologous
autologous bone marrow transplantation
autologous stem cell transplantation

B
B cell
B lymphocyte
Bacillus Calmette Gu?rin
bacteremia
bacterial toxin
barium enema
barium solution
basal cell carcinoma
benign
benign proliferative breast disease
benign prostatic hyperplasia
benign prostatic hypertrophy
benign tumor
beta carotene
beta-glucan
beta-human chorionic gonadotropin
bias
biological response modifier
biological therapy
biomarker
biopsy
biopsy specimen
biotherapy
blast
blessed thistle
blinded study
blood cell count
blood-brain barrier
blood-brain barrier disruptionBBBD.
bolus
bone marrow
bone marrow ablation
bone marrow aspiration
bone marrow biopsy
bone marrow metastases
bone marrow transplantation
bone metastases
bone scan
brachytherapy
bradycardia
brain metastasis
brain stem
brain stem glioma
brain stem tumor
breast cancer in situ
breast duct endoscopy
bronchoscope
bronchoscopy
bryostatin
burdock
Burkitt's lymphoma

C
CA 19-9 assay
cachexia
cancer
carcinogen
carcinogenesis
carcinoma
carcinoma in situ
carcinosarcoma
carcinosis
cardiotoxicity
cardiovascular
carotenoid
case report
case series
case-control study
CAT scan
cauterization
CBC
CEA
CEA assay
cell differentiation
cell proliferation
cellular adoptive immunotherapy
central nervous system
central nervous system primitive neuroectodermal tumor
c-erbB-2
cerebellopontine
cerebellum
cerebral hemisphere
cerebrospinal fluid
cerebrum
cervix
chemoembolization
chemoimmunotherapy
chemoradiation
chemotherapy
Chinese rhubarb
choroid plexus tumor
chromosome
chronic
chrysotile
clinical study
clinical trial
CNS
CNS metastasis
CNS prophylaxis
CNS tumor
cobalt 60
coenzyme Q10
colon
colon cancer
colonoscopy
colony-stimulating factor
colorectal
combination chemotherapy
comorbidity
complete blood count
complete hysterectomy
complete metastasectomy
complete remission
complete response
computed tomographic colonography
computed tomography
computerized axial tomography
computerized tomography
concurrent therapy
consecutive case series
consolidation therapy
control group
controlled clinical trial
controlled study
cooperative group
CoQ10
craniotomy
cruciferous vegetable
cryopreservation
cryosurgery
cryotherapy
CSF
CT scan
cumulative dose
cytology
cytotoxic
cytotoxic chemotherapy
cytotoxic T cell

D
da-huang
DCIS
de novo
dendritic cell
dendritic cell vaccine
differentiation
disease progression
disease-free survival
disease-specific survival
disseminate
DNA
dose-limiting
dosimetrist
double-blinded
double-contrast barium enema
ductal carcinoma in situ
Dukes' classification
dysplasia
dyspnea

E
EBV
edema
efficacy
eligibility criteria
embolization
embryonal tumor
emesis
endocrine therapy
endoscopy
endpoint
enteritis
ependymoma
epidemiology
epistaxis
Epstein-Barr virus
ER
ER-
ER+
ErbB1
erythema
erythrocyte
erythrocyte sedimentation rate
esophagitis
estrogen receptor
estrogen receptor negative
estrogen receptor positive
estrogen receptor test
estrogen replacement therapy
etiology
evaluable disease
evaluable patients
Ewing's sarcoma
extensive-stage small cell lung cancer
external radiation
external-beam radiation
extravasation

F
false-negative test result
false-positive test result
fecal occult blood test
fibroblast
fibroid
filgrastim
first-line therapy
flow cytometry
follicular mixed cell lymphoma
fractionation

G
gamma irradiation
gamma knife
gastrointestinal tract
G-CSF
gene
gene therapy
gene transfer
genetic markers
germ cell tumor
Gleason score
glial cell
glial tumor
glioblastoma
glioblastoma multiforme
glioma
gliosarcoma
GM-CSF
grade
grade IV astrocytoma
grading
granulocyte
granulocyte colony-stimulating factor

H
hairy cell leukemia
hand-foot syndrome
Hedyotis diffusa
hematologic
hematologic malignancy
hematologist
hematopoietic tissue
hemiperesis
hemoglobin
hemorrhage
hepatectomy
hepatic
hepatic arterial infusion
hepatic artery
hepatoblastoma
hepatocellular carcinoma
hepatocyte
hepatoma
HER1
HER2/neu
herba scutellaria barbatae
high grade
high-dose chemotherapy
high-energy photon therapy
high-risk cancer
histology
Hodgkin's disease
Hodgkin's lymphoma
holy thistle
hormonal therapy
hormone receptor
hormone replacement therapy
hormone responsive
hormone therapy
hormone treatment
host cell
HRT
HTLV-1
human epidermal growth factor receptor 2
human T-cell leukemia virus type 1
hydrazine sulfate
hydrocephalus
hyperbaric oxygen
hypercalcemia
hyperfractionation
hyperglycemia
hypernephroma
hyperplasia
hyperthermia therapy
hyperuricemia
hyponatremia

I
idiopathic
ileostomy
ileus
IM
immune response
immune system
immunocompetent
immunocompromised
immunodeficiency
immunotherapy
immunotoxin
implant radiation
implantable pump
in situ cancer
incidence
incisional biopsy
Indian cress
Indian elm
Indian rhubarb
Indian valerian
indolent
induction therapy
infiltrating cancer
infiltrating ductal carcinoma
inflammation
informed consent
infusion
inoperable
Institutional Review Board
intensity-modulated radiation therapy
interferon
interleukin
interstitial radiation therapy
intrahepatic
intraoperative radiation therapy
intraperitoneal chemotherapy
intrathecal
intrathecal chemotherapy
intravenous
intravenous pyelogram
investigational
IORT
IP
IRB
irradiation
irreversible toxicity
IV
J
Jewett staging system

K
Karnofsky Performance Status
KPS

L
laparoscopy
laparotomy
large cell carcinoma
latency period
lentinan
leptomeningeal
leptomeningeal cancer
leptomeningeal metastases
lesion
leucopenia
leukapheresis
leukemia
leukocyte
leukopenia
lignan
limited-stage small cell lung cancer
linac
linear accelerator
linseed
liver metastases
local cancer
local therapy
localized
locally advanced cancer
low grade
lower GI series
lumbar puncture
lymph
lymph gland
lymph node
lymphocyte
lymphocytic leukemia
lymphoma
lytic

M
magnetic resonance imaging
maintenance therapy
malignant
malignant ascites
malignant meningioma
malignant mesothelioma
mammogram
mammography
margin
mastectomy
matrix metalloproteinase
measurable disease
median
median survival time
medulloblastoma
mega-voltage linear accelerator
meningeal
meningeal metastases
meninges
meningioma
mesothelioma
mesothelium
metastases(s)/metastasis
metastasis
metastasize
metastatic
metastatic cancer
micrometastases
microwave thermotherapy
milk thistle
Miraluma test
mistletoe
mixed glioma
modality
modified radical mastectomy
monoclonal antibody
morbidity
Morinda citrifolia
MRI
mucositis
multicenter study
mutate
mutation
myalgia
myelin
myelogram
myeloid
myelosuppression

N
natural killer cell
necrosis
needle biopsy
neoadjuvant therapy
neoplasia
neoplasm
neoplastic meningitis
nephrectomy
nephrotoxicity
neuroblastoma
neurocognitive
neuroectodermal tumor
neuropathy
neurotoxicity
neutropenia
neutrophil
node-negative
node-positive
non-Hodgkin's lymphoma
noni
nonrandomized clinical trial
non-small cell lung cancer

O
objective improvement
objective response
occult stage non-small cell lung cancer
off-label
oligoastrocytoma
oligodendroglial tumor
oligodendroglioma
omega-3 fatty acid
Ommaya reservoir
oncologist
oncology
oncolysis
open label study
operable
opportunistic infection
osteosarcoma
ototoxicity
outpatient
overall survival

P
p53 gene
palliative care
palliative therapy
pancreatic cancer
paresis
paresthesias
partial remission
partial response
pathologist
pathology report
patient advocate
pediatric
performance status
perfusion
perioperative
peripheral blood
peripheral neuropathy
peritoneal
peritoneum
PET scan
phase I trial
phase I/II trial
phase II trial
phase II/III trial
phase III trial
phase IV trial
phenylacetate
phenylbutyrate
pheresis
Philadelphia chromosome
phlebitis
Pleura
Pleural Effusion
Pleurectomy
Plueral effusion
Pneumoconiosis
Pneumonectomy
p-value

S
spinal tap
spleen
stable disease
stage
stage 0 bladder cancer
stage 0 cervical cancer
stage 0 chronic lymphocytic leukemia
stage 0 colorectal cancer
stage 0 esophageal cancer
stage 0 gastric cancer
stage 0 melanoma
stage 0 nasopharyngeal cancer
stage 0 non-small cell lung cancer
stage 0 skin cancer
stage 0 testicular cancer
stage I adrenocortical cancer
stage I adult Hodgkin's lymphoma
stage I adult non-Hodgkin's lymphoma
stage I adult primary liver cancer
stage I anal cancer
stage I bladder cancer
stage I breast cancer
stage I cancer of the uterus
stage I cancer of the vulva
stage I cervical cancer
stage I childhood non-Hodgkin's lymphoma
stage I chronic lymphocytic leukemia
stage I colorectal cancer
stage I cutaneous T-cell lymphoma
stage I endometrial cancer
stage I esophageal cancer
stage I gastric cancer
stage I hypopharynx cancer
stage I kidney cancer
stage I laryngeal cancer
stage I lip and oral cavity cancer
stage I melanoma
stage I mesothelioma
stage I multiple myeloma
stage I nasopharyngeal cancer
stage I non-small cell lung cancer
stage I oropharynx cancer
stage I ovarian cancer
stage I pancreatic cancer
stage I prostate cancer
stage I skin cancer
stage I testicular cancer
stage I Wilms' tumor
stage IA soft tissue sarcoma
stage IB soft tissue sarcoma
stage II adrenocortical cancer
stage II adult Hodgkin's lymphoma
stage II adult non-Hodgkin's lymphoma
stage II adult primary liver cancer
stage II anal cancer
stage II bladder cancer
stage II breast cancer
stage II cancer of the uterus
stage II cancer of the vulva
stage II cervical cancer
stage II childhood non-Hodgkin's lymphoma
stage II chronic lymphocytic leukemia
stage II colorectal cancer
stage II cutaneous T-cell lymphoma
stage II endometrial cancer
stage II esophageal cancer
stage II gastric cancer
stage II hypopharynx cancer
stage II kidney cancer
stage II laryngeal cancer
stage II lip and oral cavity cancer
stage II melanoma
stage II mesothelioma
stage II multiple myeloma
stage II nasopharyngeal cancer
stage II non-small cell lung cancer
stage II oropharynx cancer
stage II ovarian cancer
stage II pancreatic cancer
stage II prostate cancer
stage II skin cancer
stage II testicular cancer
stage II Wilms' tumor
stage IIA soft tissue sarcoma
stage IIB melanoma
stage IIB soft tissue sarcoma
stage IIC soft tissue sarcoma
stage III adrenocortical cancer
stage III adult Hodgkin's lymphoma
stage III adult non-Hodgkin's lymphoma
stage III anal cancer
stage III bladder cancer
stage III breast cancer
stage III cancer of the uterus
stage III cancer of the vulva
stage III cervical cancer
stage III childhood non-Hodgkin's lymphoma
stage III chronic lymphocytic leukemia
stage III colorectal cancer
stage III cutaneous T-cell lymphoma
stage III endometrial cancer
stage III esophageal cancer
stage III gastric cancer
stage III hypopharynx cancer
stage III kidney cancer
stage III laryngeal cancer
stage III lip and oral cavity cancer
stage III melanoma
stage III mesothelioma
stage III multiple myeloma
stage III nasopharyngeal cancer
stage III non-small cell lung cancer
stage III oropharynx cancer
stage III ovarian cancer
stage III pancreatic cancer
stage III prostate cancer
stage III skin cancer
stage III soft tissue sarcoma
stage III testicular cancer
stage III Wilms' tumor
stage IIIA adult primary liver cancer
stage IIIA anal cancer
stage IIIA breast cancer
stage IIIB adult primary liver cancer
stage IIIB anal cancer
stage IIIB breast cancer
stage IIIC breast cancer
stage IV adrenocortical cancer
stage IV adult Hodgkin's lymphoma
stage IV adult non-Hodgkin's lymphoma
stage IV adult primary liver cancer
stage IV anal cancer
stage IV bladder cancer
stage IV breast cancer
stage IV cancer of the uterus
stage IV cancer of the vulva
stage IV cervical cancer
stage IV childhood non-Hodgkin's lymphoma
stage IV chronic lymphocytic leukemia
stage IV colorectal cancer
stage IV cutaneous T-cell lymphoma
stage IV endometrial cancer
stage IV esophageal cancer
stage IV gastric cancer
stage IV hypopharynx cancer
stage IV kidney cancer
stage IV laryngeal cancer
stage IV lip and oral cavity cancer
stage IV melanoma
stage IV mesothelioma
stage IV nasopharyngeal cancer
stage IV non-small cell lung cancer
stage IV oropharynx cancer
stage IV ovarian cancer
stage IV pancreatic cancer
stage IV prostate cancer
stage IV skin cancer
stage IV soft tissue sarcoma
stage IV Wilms' tumor
stage IVA pancreatic cancer
stage IVB pancreatic cancer
stage V Wilms' tumor
staging
standard of care
standard therapy
Statute of limitations
stem cell transplantation
stent
stereotactic biopsy
stereotactic body radiation therapy
stereotactic external-beam radiation
stereotactic radiation therapy
stereotactic radiosurgery
stomatitis
subjective improvement
survival rate
syncope
systemic
systemic chemotherapy
systemic disease

T
therapy
thoracentesis
Thoracoscopy
Thorascopy
thrombocyte
thrombocytopenia, thrombopenia
thrombosis
time to progression
TNM staging system
total parenteral nutrition
total-body irradiation
toxic
transformation
transfusion
transrectal ultrasound
transurethral biopsy
transurethral needle ablation
transurethral resection
transurethral resection of the prostate
treatment field
tumor
tumor board review
tumor burden
tumor debulking
tumor load
tumor marker
tumor necrosis factor
tumor suppressor gene
tumor-specific antigen

U
uncontrolled study
undifferentiated
unresectable
unresectable gallbladder cancer

V
vaccine therapy
valerian

W
WBC
wild clover
Wilms' tumor
Wobe-Mugos E

X
xenograft
x-ray therapy

Y
yttrium
Disclaimer
PreventMesothelioma.com is only a website. It is not an organization. The information provided should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Patients should consult with a doctor regarding their medical condition and a lawyer regarding any legal questions they have. Administration of the PreventMesothelioma.com makes no representation or warranty regarding the accuracy, reliability, completeness, currentness, or timeliness of the content, text or graphics. Links to other sites are provided only for information.


Home |  Site map |  Contact us

© 2006—2013 Preventmesothelioma.com